MRI Anastomotic Integrity of Pelvic Intestinal Anastomoses
Comparison Study of MRI-Enema and Water Soluble Contrast Enema in the Assessment of Colorectal Anastomotic Integrity Prior to Stoma Reversal
2 other identifiers
interventional
16
1 country
1
Brief Summary
This protocol describes using an MRI-Enema technique to assess the integrity of colorectal anastomoses when compared to fluoroscopic water soluble contrast enema, and provides information the participant recruitment process, participant experience and study management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 13, 2017
CompletedFirst Submitted
Initial submission to the registry
April 16, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 24, 2020
CompletedFirst Posted
Study publicly available on registry
January 22, 2021
CompletedJanuary 22, 2021
February 1, 2020
1.8 years
April 16, 2018
January 18, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
The test accuracy of (1) water-soluble contrast enema (WCSE) for the detection of colorectal anastomotic leaks. The reference standard will be consensus of Radiologist interpretation and surgical clinical assessment.
As above
Up to 36 months
The test accuracy of (2) MRI-Enema for detection of colorectal anastomotic leaks. The reference standard will be consensus of Radiologist interpretation and surgical clinical assessment.
As above
Up to 36 months
Secondary Outcomes (2)
(1) The comparative sensitivity for reported outcome variables relevant to investigation of pelvic intestinal anastomotic integrity. Including but not limited to: collection, fistula, fibrosis, lymphadenopathy, stenosis.
Up to 36 months
(2) Patient experience of WSCE vs MRI-Enema particularly relating to anxiety, comfort and embarrassment assessed on a non-validated five point questionnaire entitled 'MRI-Enema Study Patient Questionnaire v1.1'.
Up to 36 months
Study Arms (1)
Post-low pelvic colorectal anastomosis
EXPERIMENTALSingle armed study
Interventions
Eligibility Criteria
You may qualify if:
- History of colonic / anterior resection with low pelvic anastomosis including: ileorectal anastomosis, ileal pouch-anal anastomosis, colorectal anastomosis.
- Clinical requirement for assessment of anastomotic integrity (e.g. prior to reversal of defunctioning stoma)
- Ambulatory Patient
- Over 18 years of age
You may not qualify if:
- History of gadolinium allergy
- Contraindication to MRI
- Known inability to tolerate MRI (e.g. claustrophobia)
- Known inability to maintain anal continence
- Unable or unwilling to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St Mark's Hospital
London, HA1 3J, United Kingdom
Related Publications (1)
Worley G, Burling D, Corr A, Clark S, Baldwin-Cleland R, Faiz O, Jenkins J. MRI-enema for the assessment of pelvic intestinal anastomotic integrity. Colorectal Dis. 2021 Jul;23(7):1890-1899. doi: 10.1111/codi.15688. Epub 2021 May 16.
PMID: 33900000DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2018
First Posted
January 22, 2021
Study Start
June 13, 2017
Primary Completion
April 1, 2019
Study Completion
February 24, 2020
Last Updated
January 22, 2021
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will be available to members of the research team included in the study delegation log and members of the patient's normal clinical care team.